HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $8.27 billion. The enterprise value is $8.95 billion.
| Market Cap | 8.27B |
| Enterprise Value | 8.95B |
Important Dates
The next estimated earnings date is Monday, December 8, 2025, after market close.
| Earnings Date | Dec 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 86.16 million shares outstanding. The number of shares has increased by 0.59% in one year.
| Current Share Class | 86.16M |
| Shares Outstanding | 86.16M |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | -0.76% |
| Owned by Insiders (%) | 1.85% |
| Owned by Institutions (%) | 108.17% |
| Float | 84.53M |
Valuation Ratios
The trailing PE ratio is 57.64 and the forward PE ratio is 23.15. HealthEquity's PEG ratio is 1.07.
| PE Ratio | 57.64 |
| Forward PE | 23.15 |
| PS Ratio | 6.51 |
| Forward PS | 5.96 |
| PB Ratio | 3.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.43 |
| P/OCF Ratio | 22.34 |
| PEG Ratio | 1.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.78, with an EV/FCF ratio of 24.49.
| EV / Earnings | 61.36 |
| EV / Sales | 7.05 |
| EV / EBITDA | 20.78 |
| EV / EBIT | 32.70 |
| EV / FCF | 24.49 |
Financial Position
The company has a current ratio of 4.23, with a Debt / Equity ratio of 0.49.
| Current Ratio | 4.23 |
| Quick Ratio | 3.57 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.43 |
| Debt / FCF | 2.89 |
| Interest Coverage | 4.33 |
Financial Efficiency
Return on equity (ROE) is 6.78% and return on invested capital (ROIC) is 5.25%.
| Return on Equity (ROE) | 6.78% |
| Return on Assets (ROA) | 4.93% |
| Return on Invested Capital (ROIC) | 5.25% |
| Return on Capital Employed (ROCE) | 8.29% |
| Revenue Per Employee | $406,708 |
| Profits Per Employee | $46,743 |
| Employee Count | 3,120 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $39.34 million in taxes.
| Income Tax | 39.34M |
| Effective Tax Rate | 21.25% |
Stock Price Statistics
The stock price has increased by +7.70% in the last 52 weeks. The beta is 0.47, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +7.70% |
| 50-Day Moving Average | 92.55 |
| 200-Day Moving Average | 96.54 |
| Relative Strength Index (RSI) | 52.91 |
| Average Volume (20 Days) | 798,203 |
Short Selling Information
The latest short interest is 4.24 million, so 4.92% of the outstanding shares have been sold short.
| Short Interest | 4.24M |
| Short Previous Month | 5.09M |
| Short % of Shares Out | 4.92% |
| Short % of Float | 5.01% |
| Short Ratio (days to cover) | 4.79 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.27 billion and earned $145.84 million in profits. Earnings per share was $1.65.
| Revenue | 1.27B |
| Gross Profit | 842.98M |
| Operating Income | 273.62M |
| Pretax Income | 185.18M |
| Net Income | 145.84M |
| EBITDA | 430.72M |
| EBIT | 273.62M |
| Earnings Per Share (EPS) | $1.65 |
Balance Sheet
The company has $304.46 million in cash and $1.06 billion in debt, giving a net cash position of -$750.56 million or -$8.71 per share.
| Cash & Cash Equivalents | 304.46M |
| Total Debt | 1.06B |
| Net Cash | -750.56M |
| Net Cash Per Share | -$8.71 |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 24.84 |
| Working Capital | 376.26M |
Cash Flow
In the last 12 months, operating cash flow was $366.90 million and capital expenditures -$1.48 million, giving a free cash flow of $365.42 million.
| Operating Cash Flow | 366.90M |
| Capital Expenditures | -1.48M |
| Free Cash Flow | 365.42M |
| FCF Per Share | $4.24 |
Margins
Gross margin is 66.43%, with operating and profit margins of 21.56% and 11.49%.
| Gross Margin | 66.43% |
| Operating Margin | 21.56% |
| Pretax Margin | 14.59% |
| Profit Margin | 11.49% |
| EBITDA Margin | 33.94% |
| EBIT Margin | 21.56% |
| FCF Margin | 28.80% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.59% |
| Shareholder Yield | -0.59% |
| Earnings Yield | 1.78% |
| FCF Yield | 4.46% |
Analyst Forecast
The average price target for HealthEquity is $119.93, which is 24.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $119.93 |
| Price Target Difference | 24.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.69 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.69 |
| Piotroski F-Score | 8 |